Formycon Pipeline Climbs To Six As It Adds Two Biosimilars

Partner Teva In Place For Ranibizumab Launch In UK And EU

 
• By Dean Rudge
  
Arrows up (Sean Prior/Alamy Stock Photo)
2022 is set to be a landmark year for Formycon • Source: Shutterstock (Alamy Stock Photo)
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products